Table 2.
Comparison of insulin resistance indices and hsCRP between control and patients with T2DM.
| Variable | All N = 191 |
Control n = 84 | T2DM n = 107 | p-value |
|---|---|---|---|---|
| FBG mmol/dl | 7.08 ± 3.09 | 5.13 ± 1.45 | 8.68 ± 3.16 | <.001* |
| Insulin (μI/ml) | 23.76 ± 8.09 | 22.64 ± 6.11 | 24.69 ± 9.35 | .084 |
| FBG Log10 | 2.07 ± .16 | 1.96 ± .08 | 2.17 ± .14 | <.001* |
| Insulin Log10 | 1.36 ± .13 | 1.34 ± .11 | 1.37 ± .14 | .133 |
| HOMA-IR | 7.55 ± 4.44 | 5.16 ± 1.82 | 9.52 ± 4.98 | <.001* |
| HbA1c (%) | 6.82 ± 2.45 | 5.18 ± 1.46 | 8.15 ± 2.29 | <.001* |
| hsCRP mg/L | 4.07 ± 2.56 | 3.55 ± 2.23 | 4.53 ± 2.75 | .008* |
Data are represented as Mean and standard deviation.
*
Significant p-values of t-test,
*
p ≤ .05,
FBG: Fasting blood glucose, HOMA-IR: Homeostatic Model Assessment for Insulin Resistance, HbA1c: glycosylated hemoglobin, hs-CRP: high-sensitivity C-reactive protein.